Home World News Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab Alone... World News Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab Alone in Patients with ES-SCLC By Ogkologos - July 14, 2025 884 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the IMforte study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Coping With War and Cancer: How to Take Care of Your... March 11, 2022 ΚΑΡΚΙΝΟΣ ΕΝΔΟΜΗΤΡΙΟΥ February 10, 2019 Coming Full Circle on Cancer and Extrachromosomal DNA May 10, 2023 Treatment Strategy for ecDNA-Driven Tumors Shows Potential December 5, 2024 Load more HOT NEWS FDA Grants Accelerated Approval to Dostarlimab-gxly for dMMR Advanced Solid Tumours Mom’s Topless Photo Is Supposed To Encourage Breastfeeding, But Some Think... Intratumoural and Intracavitary Administration of Ipilimumab Plus Nivolumab Is Feasible and... Perioperative Pembrolizumab Plus Neoadjuvant Chemotherapy Continues to Prolong EFS and OS...
